EHZF inhibitors are a class of chemical compounds that specifically target and inhibit the activity of the enhancer of zeste homolog (EZH), a protein that plays a crucial role in gene regulation through chromatin modification. EHZF, often referred to in the context of EHZF-like proteins, is involved in the regulation of gene expression by modulating the structure of chromatin, making certain regions of the DNA more or less accessible for transcription. This modulation is critical for various cellular processes, including differentiation, development, and the maintenance of cellular identity. EHZF inhibitors interfere with these processes by blocking the enzymatic activity of EHZF proteins, thereby preventing the addition of methyl groups to histone proteins, a key mechanism by which these proteins exert their regulatory functions.
Inhibitors of EHZF are valuable tools in research aimed at understanding the complex dynamics of epigenetic regulation. By selectively inhibiting EHZF activity, researchers can study the specific roles that these proteins play in chromatin remodeling and gene expression. This can help uncover how changes in chromatin structure influence cellular behavior and contribute to the regulation of various biological processes. Additionally, EHZF inhibitors can be used to explore the broader network of interactions within the cell that are influenced by chromatin state, providing insights into how epigenetic modifications are coordinated and maintained. These inhibitors are particularly useful in experiments designed to probe the mechanisms underlying gene silencing and activation, as well as in studies focused on the long-term stability of gene expression patterns across different cell types and developmental stages. Overall, EHZF inhibitors are powerful tools for advancing our understanding of epigenetics and the intricate molecular mechanisms that regulate gene expression in eukaryotic cells.
Items 1 to 10 of 14 total
展示:
产品名称 | CAS # | 产品编号 | 数量 | 价格 | 应用 | 排名 |
---|---|---|---|---|---|---|
1,10-Phenanthroline | 66-71-7 | sc-255888 sc-255888A | 2.5 g 5 g | $23.00 $31.00 | ||
1,10-菲咯啉是一种金属离子螯合剂,可以隔离锌离子,从而可能干扰锌指蛋白(如ZNF281)的DNA结合活性。 | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
5-氮杂胞苷是一种DNA甲基转移酶抑制剂,可以改变基因表达。它可能会通过调节转录图谱间接影响ZNF281。 | ||||||
Mithramycin A | 18378-89-7 | sc-200909 | 1 mg | $54.00 | 6 | |
米曲霉素A是一种DNA结合抗肿瘤抗生素,可抑制SP1转录因子。由于ZNF281也是一种转录因子,因此可能对其活性产生潜在影响。 | ||||||
Tamoxifen | 10540-29-1 | sc-208414 | 2.5 g | $256.00 | 18 | |
他莫昔芬是一种选择性雌激素受体调节剂(SERM),用于乳腺癌治疗。鉴于ZNF703与乳腺癌有关,他莫昔芬可能会影响其表达。 | ||||||
Letrozole | 112809-51-5 | sc-204791 sc-204791A | 25 mg 50 mg | $85.00 $144.00 | 5 | |
芳香酶抑制剂来曲唑可能会通过雌激素调节间接影响乳腺癌中的ZNF703表达。 | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $149.00 $470.00 $620.00 $1199.00 $2090.00 | 33 | |
作为HDAC抑制剂,曲古抑菌素A可以改变染色质结构,并可能影响ZNF703的转录。 | ||||||
Ribociclib | 1211441-98-3 | sc-507367 | 10 mg | $450.00 | ||
另一种CDK4/6抑制剂利博西立可能会在特定的细胞环境中间接调节ZNF703的表达。 | ||||||
Gefitinib | 184475-35-2 | sc-202166 sc-202166A sc-202166B sc-202166C | 100 mg 250 mg 1 g 5 g | $62.00 $112.00 $214.00 $342.00 | 74 | |
吉非替尼是一种表皮生长因子受体(EGFR)抑制剂,可影响多个下游信号通路,并可能对ZNF703的表达产生间接影响。 | ||||||
Lapatinib | 231277-92-2 | sc-353658 | 100 mg | $412.00 | 32 | |
作为HER2/neu和表皮生长因子受体(EGFR)的抑制剂,拉帕替尼可能间接影响HER2阳性乳腺癌中ZNF703的表达。 | ||||||
Everolimus | 159351-69-6 | sc-218452 sc-218452A | 5 mg 50 mg | $128.00 $638.00 | 7 | |
依维莫司通过抑制mTOR,可影响多种细胞过程,并可能间接影响ZNF703的表达。 |